Summary
Modified nucleosides derived predominantly from transfer ribonucleic acid (tRNA) have been studied as possible tumor markers. In this paper a reversed-phase high-performance liquid chromatographic (RP-HPLC) method has been applied to study 15 normal and modified nucleosides in serum. The nucleoside levels in normal human serum were established, and the concentrations of 15 nucleosides in serum from 19 cancer patients were determined. It was found that the concentrations of modified nucleosides were significantly higher in patient sera. Based on 15 nucleoside concentrations in serum, factor analysis could classify correctly 90% of cancer patients from the normal humans. Further work showed that urine was slightly better than serum when determining nucleosides as biological marker candidates. More work is ongoing to determine the clinical usefulness of modified nucleosides as tumor markers.
Similar content being viewed by others
References
Mandel, L.R.; Srinivasan, P.R.; Borek, E.Nature 1996,209, 586–588.
Weissman, S.M.; Eisen, A.Z.; Lenrio, M.J.Lab. Clin. Med 1962,60, 40–47.
Srinivasan, P.R.; Borek, E.Proc. USA 1966,56, 1003–1009.
Borek, E.Cancer Res. 1971,31, 596–597.
Borek, E.; Baliga, B.S.; Gehrke, C.W.; Kuo, C.W.; Belman, S.; Troll, W.; Waalkes, T.P.Cancer Res. 1977,37, 3362–3366.
Kerr, S.J. InMethods Cancer Res: Busch, H. Eds,1978,15, 163–185.
Langridge, J.I.; McClure, T.D.; Shakawi, S.; Fielding, A.; Schram, K.H.; Newton, R.P.Rapid Commun. Mass Spectrum 1993,7, 427–434.
Gehrke, C.W.; Kuo, K.C.Chromatography and Modification of Nucleosides. Par C. Elsevier, Amsterdam, 1990.
Rasmuson, T.; Bjork, G.R.Acta Oncol. 1995,34, 61–67.
Waalkes, T.P.; Abeloff, M.D.; Ettinger, D.S.; Woo, K.B.; Gehrke, C.W.; Kuo, K.C.; Borek, E.Eur. J. Cancer Clin. Oncol 1982,18, 1267–1274.
Tamura, S.; Fujii, J.; Nakano, T.; Hada, T.; Higashino, K.Clin Chim. Acta 1986,154, 125–132.
Rasmuson, T.; Bjork, G.R.; Damber, L.; Jacobsson, L.; Jeppsson, A.; Stigbrand, T.; Westman, G.Acta Oncol. 1987,26, 261–267.
Vold, B.S.; Kraus, L.E.; Rimer, V.G.; Coombes, R.C.Cancer Res. 1986,46, 3164–3167.
Rasmuson, T.; Bjork, G.R.; Damber, L.; Holm, S.E.; Jaconsson, L.; Jeppsson, A.; Stigbrand, T.; Westman, G.Acta Radiol. Oncol. 1984,23, 27–32.
Gehrke, C.W.; Kuo, K.C.; Waalkes, T.P.; Borek, E.Cancer Res. 1979,39, 1150–1153.
Koshida, K.; Harmenberg, J.; Stendahl, U.; Wahren, B.; Borgstrom, E.; Helstrom, L. Andersson, A.Urol. Res. 1985,13, 213–218.
Borek, E.; Waalkes, T.P.; Gehrke, C.W.Cancer Detect Prev. 1983,6, 67–71.
Borek, E.; Sharma, O.K.; Buschman, F.L.; Cohn, D.L.; Penley, K.A.; Judson, F.N.; Dobozin, B.S.; Horsburgh, C.R.Jr.; Kirkpatrick, C.H.Cancer Res. 1986,46, 2557–2561.
Nakano, K.; Nakao, T.; Schram, K.H.; Hammargren, W.M.; McClure, T.D.; Katz, M.; Petersen, E.Clin. Chim. Acta 1993,218, 169–183.
Limbach, P.A.; Crain, P.F.; McCloskey, J.A.Nucleic Acids Research 1994,22, 2183–2196.
Schoch, G.; Sander, G.; Topp, H.; Heller-Schoch, G. In:Chromatography and Modification of Nucleosides. Part C: Gehrke, C.W.; Kuo, K.C. Eds, Elsevier, Amsterdam, 1990, C389-C441.
Nakano, K.; Nakao, T.; Schram, K.H.; Hammargren, W.M.Nucleic Acids Symp. Ser. 1991, 125–126.
Marvel, C.C., Del Rowe, J.; Bremer, E.G.; Moskal, J.R.Mol. Chem. Neuropathol. 1994,21, 353–368.
Topp, H.; Duden, R.; Schoch, G.Clin. Chim. Acta 1993,218, 73–82.
Schoch, G.; Topp, H.; Held, A.; Heller-Schoch, G.; Ballauff, A.; Manz, F.; Sander, G.Eur. J. Clin. Nutr. 1990,44, 647–658.
Sander, G.; Topp, H.; Heller-Schoch, G.; Wieland, J.; Schoch, G.Clin. Sci. 1986,71, 367–374.
Sander, G.; Topp, H.; Wieland, J.; Heller-Schoch, G.; Schoch, G.Hum. Nutr. Clin. Nutr. 1986,40, 103–118.
Samuelsson, T.Nucleic Acids Res. 1991,19, 6139–6144.
Trewyn, R.W.; Glaser, R.; Kelly, D.R.; Jackson, D.G.; Graham, W.P.; Speicher, C.E.Cancer 1982,49, 2513–2517.
Nakano, K.; Shindo, K.; Yasaka, T.J. Chromatogr. 1985,343, 21–33.
McEntire, J.E.; Kuo, K.C.; Smith, M.E.; Stalling, D.L.; Richens, J.W. Jr.; Zumwalt, R.W.; Gehrke, C.W.; Papermaster, B.W.Cancer Res. 1989,49, 1057–1062.
Pane, F.; Savoia, M.; Fortunato, G.; Camera, A.; Rotoli, B.; Salvatore, F.; Sacchetti, L.Clin. Biochem. 1993,26, 513–520.
Mitchell, E.P.; Evans, L.; Schultz, P.; Madsen, R.; Yarbro, J.W.; Gehrke, C.W.; Kuo, K.J. Chromatogr. 1992,581, 31–40
Kuo, K.C.; Esposito, F.; McEntire, J.E.; Gehrke, C.W. InProceedings of the Third International Conference Lacco Ameno d'Ischia, Naples, Italy; Cimino, F.; Birkmayer, G.D.; Klavins, J.V.; Pimental, E.; Salvetore, F. Eds April 23–26, 1986, Walter de Gruyter & Co. Berlin, 1987, 519–544.
Pane, F.; Oriani, G.; Kuo, K.C.; Gehrke, C.W.; Salvatore, F.; Sacchetti, L.Clin. Chem. 1992,38, 671–677.
Nass, G. Ed.Modified Nucleosides and Cancer, Springer-Verlag, New York, Berlin, 1983.
Gehrke, C.W.; Kuo, K.C.; Waalkes, T.P.; Borek, E.Cancer Res. 1979,39, 1150–1153.
Gehrke, C.W.; Kuo, K.C.J. Chromatogr. 1989,471, 3–36.
Masuda, M.; Nishihira, T.; Itoh, K.; Mizugaki, M.; Ishida, N.; Mori, S.Cancer 1993,72, 3571–3578.
Reynaud, C.; Bruno, C.; Boullanger, P.; Grange, J.; Barbesti, S.; Niveleau, A.Cancer Lett. 1992,61, 255–262.
Liebich, H.M.; Di Stefano, C.; Wixforth, A.; Schmid, H.R.J. Chromatogr. A. 1997,763, 193–197.
Xu, G.; Di Stefano, C.; Liebich, H.M.; Zhang, Y.; Lu, P.J Chromatogr. B 1999,732, 307–313.
Liebich, H.M.; Di Stefano, C.; Xu, G.; Wahl, H.G.; Kim, J.H. 21st International Symposium on Chromatography, Stuttgart, Sept. 15–20, 1996, 340.
Liebich, H.M.; Xu, G.; Di Stefano, C.; Lehmann, R.Chromatographia 1997,45, 396–401.
Liebich, H.M.; Xu, G.; Di Stefano, C.; Lehmann, R.J. Chromatogr. A 1998,793, 341–347.
Zhao, R.; Xu, G.; Yue, B.; Liebich, H.M.; Zhang, Y.J. Chromatogr. A 1998,828, 489–496.
Xu, G.; Lu, X.; Zhang, Y.; Lu, P.; Di Stefano, C.; Lehmann, R.; Liebich, H.Chinese J. Chromatogr. 1999,17, 97–101.
Zhao, R.; Xu, G.; Yue, B.; Liebich, H.M.; Zhang, Y.PITTCON'99 Abstracts 1999, 895.
Bartels, H.; Bohmer, M.; Heierli, C.Clin. Chim. Acta 1972,37, 193–197.
Pan, Z.; Si, S.; Nie, S.; Zhang, M. Factor Analysis in Chemistry, Hefe, China. The University of Science and Technology of China, 1992, 109–210.
Massart, D.L.; Vandeginste, B.G.M.; Deming, S.N.; Michotte, Y.; Kaufman, L. Chemometrics: A Textbook, Elsevier, New York, 1998.
Salvatore, F.; Sacchetti, L.; Savoia, M.; Pane, F.; Russo, T.; Colonna, A.; Cimino, F. InChromatography and modification of nucleosides. Part C: Gehrke, C.W.; Kuo, K.C. Eds, Elsevier, Amsterdam, 1990, C251-C278.
Kuo, K.C.; Phan, D.T.; Williams, N.; Gehrke, C.W. InChromatography and Modification of Nucleosedes, Part C: Gehrke, C.W.; Kuo, K.C. Eds, Elsevier, Amsterdam, 1990, C41-C113.
Apell, G.; Buschman, F.L.; Sharma, O.K.J. Chromatogr. 1986,374, 149–154.
Russo, T.; Colonna, A.; Esposito, F.; Salvatore, F.; Cimino, F.It. J. Biochem. 1982,31, 75–78.
Savoia, M.; Russo, T.; Rippa, E.; Bucci, L.; Mazzeo, F.; Cimino, F.; Salvatore, F.J. Tumor Marker Oncol. 1986,1, 61–68.
Topp, H.; Sander, G.; Heller-Schoch, G.; Schoch, G.Anal. Biochem. 1987,161, 49–56.
Sharma, O.K.; Fischbein, A. InChromatography and modification of nucleosides, Part C: Gehrke, C.W.; Kuo, K.C. Eds, Elsevier, Amsterdam, 1990, C321-C340.
Hartwick, R.A.; Krstulovich, A.W.; Brown, P.R.J. Chromatogr. 1979,186, 659–664.
Zakaria, M.; Brown, P.R.; Farnes, M.P.; Burker, B.E.Clin. Chim. Acta 1982,126, 69–80.
Schoch, G.; Thomale, J.; Lorenz, H.; Suberg, H.; Karsten, U.Clin. Chim. Acta 1980,108, 247–257.
Schlimme, E.; Boos, K.S.; Kagemeier, E.; Kemper, K.; Meyer, V.; Hobler, H.; Schnelle, T.; Weis, M.J. Chromatogr. 1986,378, 349–360.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xu, G., Enderle, H., Liebich, H. et al. Study of normal and modified nucleosides in serum by RP-HPLC. Chromatographia 52, 152–158 (2000). https://doi.org/10.1007/BF02490446
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02490446